The North Carolina Department of Natural Resources is accepting applications for the use of “BioBios” as a bio-medical product.
The department has not yet announced a deadline for submitting applications for BioBios licenses, which can cost up to $10,000 per product.
The BioBros are manufactured by a private company and come in two types: “Bio-Liquids” that are produced from food products such as milk, yogurt, or juice, and “BioPens” that come in liquid form, which are typically used in the production of antibiotics, antifungals, and probiotics.
“Biologically produced Bio-Lignins are the basis of Bio-Pens and Bio-Products, as well as Bio-Chemicals, which include bio-based vaccines and medicines,” the department said in a press release.
These products are produced using a unique process called “genomics,” which uses “a variety of technologies to make the product,” according to the press release, which notes that “there are some differences between the Genomics and Manufacturing process that may cause some concern for the public health implications of using Bio-Bios.”
While the bio-products are typically consumed by consumers, the department says it “may also be used for other purposes in the future.”
“BioBiotics are available in many forms, including bio-liquid and bio-pulsed formulations.
We also have plans to make bio-liquids available in a powdered form,” the press note says.
For now, the BioBos are only available for personal use, with no commercial applications.
However, the bio products have the potential to be used in research.
There’s no indication that the BioBs will be used by the federal government in a vaccine production program, but the department did note that the bio product is “an essential component of the U.S. Food and Drug Administration’s (FDA) vaccine manufacturing program.”
A spokesman for the department declined to comment on whether it would seek approval from the FDA for its use in vaccines.
The bio-samples are already being tested by scientists and doctors to determine the safety of the products, and the department is looking to expand its program to include the Bio-Lab, which is the only type of facility that can make and sell bio-absorbent products.
In addition to BioBabs, the Department of Health and Human Services is also planning to test BioPens, which could eventually be sold as well.
But the bio items are still in their infancy.
One of the major challenges in the development of bio-materials is how to ensure that they are safe, and how to keep them safe during their manufacturing process.
The use of bio products in the U, however, has the potential for creating jobs.
According to the Department’s press release , the department expects the production and sale of bioabsorbents to create approximately 1,500 jobs over the next four years.